..

..
..
..
..
Gilead prices COVID-19 drug candidate remdesivir at US$390 per vial in the US https://t.co/zbgILiwK5o pic.twitter.com/VOeFC4HBwE
— CNA (@ChannelNewsAsia) June 29, 2020
..
Gilead's Covid-19 drug remdesivir will be priced at $3,120 for a typical U.S. patient with commercial insurance https://t.co/CMmXHdn1cg
— The Wall Street Journal (@WSJ) June 29, 2020
..
Highlights of the shock testimony of Professor Raoult at the French National Assembly on June 24. He criticizes the poor response to the COVID-19 crisis, the ban on hydroxychloroquine, and many more aspects. He also calls for an investigation into Gilead. https://t.co/AJ8498N381 pic.twitter.com/CCwxTAT17u
— Jean-Pierre K. (@jpkiekens) June 28, 2020
..
I can’t afford this. My insurance will not cover it. I am only going to ask for intravenous Vitamin C starting at 5000 mg. If my doctor refuses, I shall have to look for another doctor.
In Malaysia, treatment is at a govt hospital and the bill will be a fraction of the cost in a private hospital. However, you won’t get Gilead’s remdesivir. Just hydroxychloroquine 🤗